ASCPT SIGN IN
Username:
Password:
SEARCH
Scientific Horizons and Opportunities in Pharmacogenomics Research

This session is sold out.

Organized by the Pharmacogenomics Research Network (PGRN)
Wednesday, March 9, 2016 | 8:00 AM – 2:00 PM

The field of pharmacogenomics received considerable attention when President Obama launched the Precision Medicine Initiative earlier this year. This session, organized by the Pharmacogenomics Research Network (PGRN) is open to all ASCPT attendees, and will focus on new research horizons in pharmacogenomics and precision medicine. The session includes an interactive panel discussion with different stakeholders who will describe emerging opportunities for research partnerships in pharmacogenomics. This session is intended for a diverse range of scientists across multiple sectors who are interested in learning about the latest research in pharmacogenomics and precision medicine. Importantly, speakers in the session will describe new opportunities for collaborative research and access to innovative resources to advance research in basic and translational pharmacogenomics.

If you plan to attend this session as well as the ASCPT Annual Meeting, please indicate so on the 2016 ASCPT Meeting registration form.  If you are planning only to attend the PGRN session, please contact ASCPT staff at meetings@ascpt.org or 703-836-6981.

Meeting Agenda

  7:00 am (60 min)
Breakfast



8:00 am (15 min)
Overview of PGRN Transition

Rochelle M. Long, PhD, National Institutes of Health, Bethesda, MD 

Emerging Horizons in Pharmacogenomics Research


Moderator:
Mary Relling, PharmD, St. Jude Children's Research Hospital, Memphis, TN



8:15 am (30 min)
Center for Precision Medicine in Leukemia: Genome Variants Influencing de novo and Acquired Resistance to Antileukemic Agents

William E. Evans, PharmD, St. Jude Children's Research Hospital, Memphis, TN



8:45 am (30 min)
The Vanderbilt P50 Center: New Approaches to Evaluating the Genetics of Adverse Drug Reactions

Elizabeth J. Phillips, MD, Vanderbilt University, Nashville, TN



9:15 am (30 min)
System Pharmacogenomics of Statin Therapy

Ronald M. Krauss, MD, Children's Hospital Oakland Research Institute, Oakland, CA



9:45 am (30 min)
Improving Clinical Outcomes Through Pharmacogenomics

Julie A. Johnson, PharmD, University of Florida, Gainesville, FL

  10:15 am (15 min)
Break

 Pharmacogenomics Resources of the PGRN


Moderator:
Sook Wah Yee, PhD, Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA



10:30 am (25 min)
Warfarin Pharmacogenomics in Alaskan Natives: Focus on Novel Pharmacogene Variant Function

Allan E. Rettie, PhD, University of Washington, Seattle, WA



10:55 am (25 min)
Clinical Pharmacogenetics Implementation Consortium

Mary Relling, PharmD, St. Jude Children's Research Hospital, Memphis, TN



11:20 am (25 min)
PharmGKB: Pharmacogenomics Knowledge for Precision Medicine

Teri E. Klein, PhD, Genetics Department, Stanford University, Palo Alto, CA 
  11:45 am (30 min)
Lunch

Panel Discussion on Partnership Opportunities


Moderator:
Kathleen M. Giacomini, PhD, School of Pharmacy, Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA



Moderator:
Rachel F. Tyndale, PhD, Section Head, Pharmacogenetics, Centre for Addiction and Mental Health, Department of Pharmacology, University of Toronto, Toronto, ON, Canada

  12:15 pm (10 min)
Introduction by Moderator
Kathleen M. Giacomini, PhD, University of California San Francisco, CA



12:25 pm (10 min)
PGRN Website

Megan Riel-Mehan, University of California San Francisco, San Francisco, CA

Panelists
 Joshua C. Denny, MD, Vanderbilt University Medical Center, Nashville, TN
Michael Pacnowski, PharmD, MPH, Silver Spring, MD


Alan R. Shuldiner, MD, Regeneron Genetics Center, Tarrytown, NY


 Richard Weinshilboum, MD, Mayo Clinic Rochester, Rochester, MN
 




1:30 pm (30 min)
Pharmacogenomic Implementation Initiatives in Europe

Ron H.N van Schaik, PhD, Erasmus University, Rotterdam, Netherlands
Jesse J. Swen, PharmD, PhD, Leiden University Medical Center, Netherlands



528 N Washington St, Alexandria, VA 22314 |  Ph: 703.836.6981 |  info@ascpt.org